An Emerging Role of mTOR in Lipid Biosynthesis

被引:509
作者
Laplante, Mathieu [1 ]
Sabatini, David M. [1 ,2 ,3 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA
[3] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA
关键词
ACTIVATED RECEPTOR-GAMMA; MAMMALIAN TARGET; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; SREBP ACTIVITY; RAPAMYCIN; INSULIN; ACID; ADIPOGENESIS; METABOLISM;
D O I
10.1016/j.cub.2009.09.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid biosynthesis is essential for the maintenance of cellular homeostasis. The lipids produced by cells (glycerolipids, fatty acids, phospholipids, cholesterol, and sphingolipids) are used as an energy source/reserve, as building blocks for membrane biosynthesis, as precursor molecules for the synthesis of various cellular products, and as signaling molecules. Defects in lipid synthesis or processing contribute to the development of many diseases, including obesity, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, and cancer. Studies published over the last few years have shown that the target of rapamycin (TOR), a conserved serine/threonine kinase with an important role in regulating cell growth, controls lipid biosynthesis through various mechanisms. Here, we review these findings and briefly discuss their potential relevance for human health and disease.
引用
收藏
页码:R1046 / R1052
页数:7
相关论文
共 48 条
  • [11] Inhibition of insulin signaling and adipogenesis by rapamycin:: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1
    El-Chaâr, D
    Gagnon, A
    Sorisky, A
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (02) : 191 - 198
  • [12] Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
    Feldman, Morris E.
    Apsel, Beth
    Uotila, Aino
    Loewith, Robbie
    Knight, Zachary A.
    Ruggero, Davide
    Shokat, Kevan M.
    [J]. PLOS BIOLOGY, 2009, 7 (02) : 371 - 383
  • [13] SREBP-1c transcription factor and lipid homeostasis:: Clinical perspective
    Ferre, P.
    Foufelle, F.
    [J]. HORMONE RESEARCH, 2007, 68 (02) : 72 - 82
  • [14] Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion
    Gagnon, A
    Lau, S
    Sorisky, A
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 189 (01) : 14 - 22
  • [15] GARCIAMARTINEZ JM, 2009, BIOCHEM J, DOI DOI 10.1042/BJ20091035
  • [16] Defining the role of mTOR in cancer
    Guertin, David A.
    Sabatini, David M.
    [J]. CANCER CELL, 2007, 12 (01) : 9 - 22
  • [17] Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c
    Hegarty, BD
    Bobard, A
    Hainault, I
    Ferré, P
    Bossard, P
    Foufelle, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 791 - 796
  • [18] SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
    Horton, JD
    Goldstein, JL
    Brown, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) : 1125 - 1131
  • [19] Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin
    Huffman, TA
    Mothe-Satney, I
    Lawrence, JC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 1047 - 1052
  • [20] Rictor/TORC2 Regulates Caenorhabditis elegans Fat Storage, Body Size, and Development through sgk-1
    Jones, Kevin T.
    Greer, Elisabeth R.
    Pearce, David
    Ashrafi, Kaveh
    [J]. PLOS BIOLOGY, 2009, 7 (03): : 604 - 615